Neurotech International Limited (ASX:NTI)
Neurotech International Limited is an Australia-based medical device and solutions company. The Company operates through its wholly owned, Malta-based subsidiary AAT Research Limited. The Company is focusing on neuro-protective, anti-inflammatory and neuro-modulatory activities of NTI/Dolce cannabis strains. The Company through its class II device Mente is focused on development and commercialisation of technological solutions for the screening and treatment of symptoms associated with conditions such as autism. Mente is, a home therapy that is clinically proven to increase engagement and relaxation in autistic children with elevated Delta band brain activity.